Trump Signs Law to Launch Dollar 2.0
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Some Social Security Recipients Won't Have To Wait Until 2026 For COLA Hike
Social Security and SSI recipients will receive a 2.8% cost-of-living adjustment in 2026, with SSI beneficiaries seeing the increase a day earlier due to a federal holiday.
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit the most.
Pfizer Clinches $10 Billion Deal To Buy Obesity Drug Maker Metsera, Outbidding Novo Nordisk In Fierce Battle For Weight-Loss Market Dominance
Nvidia CEO Jensen Huang cautioned Elon Musk against underestimating the challenges of semiconductor manufacturing, saying building a chip fab like TSMC's is "extremely hard."
AP Lifestyles Digest for week of Nov. 10
Here is the AP Lifestyles Digest for the week of Nov. 10. Note AP's Holiday Gift Guide Digest is included at the end; the gift guides move Wednesday.
The Stock-Picking AI That Could Triple Your Money This Year - Ad
Early users could have already tripled their money every single year this AI has been live, based on the average winning trade spotted - WITHOUT having to check the news, WITHOUT watching the Fed, and WITHOUT all the stress most traders have to deal with. For now, you can try this AI yourself, completely free of charge - no email, no credit card.
Elon Musk-Led Neuralink's First Patient Details Life Post Receiving BCI Chip — Eyes Second Implant: 'It Gave Me Hope'
The first recipient of Elon Musk-led Neuralink's BCI implant shares his experiences and how it changed his life, eyeing a second implant.
Baxter Warns Of Potential Device Tampering In Life2000 Ventilator Recall
Baxter recalls its Life2000 ventilators after a cybersecurity flaw prompts an FDA high-risk alert, urging patients to stop use and seek replacement options.
Why Is a $116B Mining Giant Backing a $10M Firm? - Ad
Rio Tinto rarely makes early-stage bets. Yet one small N. American firm earned its trust with projects in lithium, uranium, and titanium - all vital to U.S. defense and energy independence.
Trump Says He Doesn't Want To Extend Obamacare Subsidies At All, But Concedes Measures May Be Taken To 'Get Something Else Done'
Trump rejects two-year ACA subsidy extension plan, despite reports of circulated draft framework. White House exploring options to prevent premium hikes.
Sanofi Faces Surprise HQ Search As French Authorities Expand Tax Probe
Sanofi faces a surprise tax probe in France as Dupixent secures EU approval for treating chronic spontaneous urticaria.
Global Demand for Defense Metals Is Surging 7X - Ad
Lithium, uranium and titanium are at the center of a global race. Nations are scrambling to secure them for fighter jets, EVs, and reactors. One N. American project could help fill the West's critical-minerals gap.
The Miami Project to Cure Paralysis follows science and steady funding to a broader mission
Marc Buoniconti said his father, , explained the secret to the success of their nonprofit and its fundraising efforts simply: “We’re just not good listeners.”
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.
The U.S. Wants Metal Independence - And This Nevada Opportunity Fits the Moment - Ad
Washington's push for domestic copper, silver, gold, and tungsten is reshaping the resource landscape. Their neighbor's multi-metal hits, supported by $6M in federal funding and a 300%+ YTD surge, confirmed this Nevada corridor is the right kind of ground. Now another early-stage explorer has stepped into the same trend as interest accelerates.
Trump Officials Retreat On Social Security Disability Rule After Advocates Sound Alarm
Trump administration drops rule to make it harder for older Americans to qualify for Social Security disability benefits after criticism.
Babies who drank ByHeart formula got sick months before botulism outbreak, parents say
As health officials investigate more than linked to ByHeart baby formula since August, parents who say their children were sickened with the same illness months before the current outbreak are demanding answers, too.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
'Rental Family' spotlights real-life Japanese businesses that offer fill-in relatives, friends
TOKYO (AP) — Ryuichi Ichinokawa's life could be right out of the movie “Rental Family” as the founder nearly two decades ago of the Heart Project business in Japan, which he bills as a surrogate attendance service complete with furnishing of extras and family members.
Short Seller Alleges Praxis Precision's Potential $3 Billion Drug 'A House Of Cards'
Short seller challenges Praxis' Phase 3 ulixacaltamide data, alleging major flaws that could undermine FDA approval and the company's valuation.
Legally "Skim" $6,361 Into Your Account? - Ad
A former hedge fund manager is now sharing his "Skim Codes" with regular people. They're not stocks. They're not crypto. They're 18-character codes designed to profit from recent market conditions. All you have to do is punch them into an ordinary brokerage account. 84% of these codes have given people the chance to generate cash payouts so far... and his next code is going out any day now.
LOCALIZE IT: At least 30 babies in 15 states sickened by growing infant botulism outbreak
EDITORS/NEWS DIRECTORS:
Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment
Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.
AI Learns To Forecast U.S. Stock Prices, To The Cent, Days In Advance - Ad
Breakthrough AI created by former Air Force nuclear missile coder would have already gotten you in early on Amazon, Meta, and Tesla.
FDA Clears Arrowhead Pharma's First-Ever Home Injection For Rare Fat Disorder
Arrowhead Pharmaceuticals won FDA approval for Redemplo (plozasiran), an siRNA drug reducing high triglycerides in adults with rare FCS.
MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
NEW YORK (AP) — The MacArthur Foundation is awarding $100 million to a private pandemic prevention network across Africa, offering critical support to infectious disease surveillance at a time when governments are reducing global health spending.
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after January 29, it may be too late.
Novo Nordisk Leans Into Affordability Amid Rising Competition
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger Wegovy pill rollout.
Novo chops Wegovy prices, but doctors still see affordability challenges for patients
Novo Nordisk is chopping prices again for its popular obesity treatment Wegovy, but doctors say the expense will remain challenging for patients without insurance.
Elon's Optimus to Mint New "Musk Millionaires" as Soon as Jan 26? - Ad
Elon Musk may be set to create more "Musk Millionaires" as soon as January 26... Because on that day, he's expected to officially launch his Optimus robot... An AI-powered robot that Elon himself says will be capable of "doing anything bar nothing". Now, it's important to point out that Elon hasn't released it to the public yet... But ahead of the launch, one Silicon Valley insider has identified a "backdoor way" for any American to invest in Optimus with a regular brokerage account...
Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing
Hims & Hers launches Labs, offering annual biomarker testing plans with doctor-developed guidance and expanded diagnostics planned across key health categories.
Climate leaders are talking about 'overshoot' into warming danger zone. Here's what it means
BELEM, Brazil (AP) — The world's climate leaders are conceding that will shoot past a hard limit they set a decade ago in hopes of keeping the planet out of a danger zone. But they're not conceding defeat.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit the most.
Families of two babies sickened by infantile botulism sue ByHeart over recalled formula
The parents of at least two babies sickened in an outbreak are suing the makers of the ByHeart baby formula at the heart of a .
UK commits to ensuring 'poignant' COVID memorial wall in London will be preserved
LONDON (AP) — The British government said Thursday that a memorial wall in London created by those who lost loved ones during the coronavirus pandemic will be preserved.
The Stock-Picking AI That Could Triple Your Money This Year - Ad
Early users could have already tripled their money every single year this AI has been live, based on the average winning trade spotted - WITHOUT having to check the news, WITHOUT watching the Fed, and WITHOUT all the stress most traders have to deal with. For now, you can try this AI yourself, completely free of charge - no email, no credit card.
A flotilla kicks off the People's Summit for activists at UN climate talks
BELEM, Brazil (AP) — As United Nations climate talks rolled on Wednesday at the elaborate new venues built for the summit, many of the activists eager to shape the talks took to the water.
Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks
Bayer's Q3 earnings rose on strong Crop Science and Pharma sales, with CEO Bill Anderson confident in meeting the company's upgraded 2025 guidance.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.